MOREADITH RANDALL (Chief Scientific Officer) sold 4.10K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.7K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001301120-25-000039
Officer· Chief Scientific Officer
Since Feb 2026
-4.10K
Net shares
Net seller
$10.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.10K acquired · 8.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.10K
Price / share
$0.06
Trade value
$246.00
% of position
New position
12/23/2025
0.00→4.10K
Common Stock
Direct
Shares
−4.10K
Price / share
$2.60
Trade value
$10.66K
% of position
New position
12/23/2025
4.10K→0.00
Total
Net shares
+0.00
Net value
-$10.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2025 | M · Option Exercise | +4.10K | $0.06 | $246.00 | New position | 0.00 | 4.10K |
| Common Stock Direct | 12/23/2025 | S · Sale | −4.10K | $2.60 | $10.66K | New position | 4.10K | 0.00 |
| Total | +0.00 | -$10.41K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
4.10K shares
Shares
−4.10K
Strike price
0.06
Held after
352.19K
Exercisable
—
12/23/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock4.10K shares | 12/23/2025 | M · Option Exercise | −4.10K | 0.06 | — | 352.19K |